All Articles

Shipping giant Hafnia declares a robust Q3 dividend, backed by strong earnings and a bullish market outlook. Here’s what it means for investors.

A Prague-listed powder metallurgy specialist is diversifying into medical, beauty, and security, proving its financial strength and innovation.

Karolinska Development seeks a massive capital injection, risking huge shareholder dilution to fund a promising drug pipeline and rebrand as KDventures.

A 30% surge in Indian family travel to cold climates reveals a major market shift, powered by tech platforms, simplified visas, and strategic airline expansion.

With a $300M Series B, this German AI lab is moving past image generation to build AI that truly understands and reasons about the visual world.

Deepgram brings its streaming voice AI to Amazon SageMaker, removing complex barriers and letting businesses build secure, real-time voice apps in AWS.

A major Thai brokerage is adopting advanced US analytics, signaling a new era of financial sophistication and transparency for Southeast Asia's investors.

Canary Capital’s dominance with XRP and HBAR ETFs signals a major shift. We explore how targeted digital asset funds are rewriting the rules for investors.

In-store traffic fell, but spending rose. Beyond the headlines, a new, calculated consumer is reshaping the future of holiday retail forever.

A junior miner with vast Quebec graphite reserves appoints a finance veteran. Is this the move that unlocks a key piece of North America's EV supply chain?

Saba Capital's fund boasts a high yield, but a closer look reveals nearly 60% of payments are a return of capital. What does this mean for investors?

Saba's BRW fund boasts a double-digit yield, but over half is a return of capital. We decode what this financial engineering means for investors.

NEOS Investments' eye-popping ETF distributions, some over 26%, attract investors. But how sustainable are these payouts and what are the hidden risks?

Mayor Johnson's plan to tax tech and big business faces fierce opposition. Can Chicago solve its deficit without driving away its economic engine?

Adicet Bio's recent inducement grant is more than a routine hire. It’s a key move in biotech's talent war and a signal of its strategic future.

With a new $91.5M Centre for Fusion Energy, Canada is leveraging its nuclear past to build a clean energy future. But can it win the global race?

The Estonian manufacturer shows Q3 operational gains, but ballooning debt and a costly real estate gamble raise questions about its long-term stability.

As Davion Healthcare prepares its NASDAQ debut, its AI-powered home tests could decentralize diagnostics, but faces a competitive, regulated market.

A new rugged phone boasts 50-meter IR night vision, a massive battery, and a disruptive price. Is this the future for field work and exploration?

Xeriant is betting its future on a high-discipline R&D unit. By mimicking giants like Lockheed and Palantir, can it turn ambition into revenue?